184 filings
Page 7 of 10
6-K
6vw8gkzn 2m0nclp
15 Oct 21
Innate Pharma S.a. 6-K
6:00am
6-K
7hqo cg1z0x
23 Sep 21
Current report (foreign)
6:30am
6-K
no9 9s1m0xk4mxv
17 Sep 21
Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
7:45am
6-K
6mfiu5nlc2ot
15 Sep 21
Innate Pharma Reports First Half 2021 Financial Results and Business Update
6:07am
6-K
v4g4w2tv1t9ox6y
7 Sep 21
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
6:30am
6-K
djo1gq
2 Sep 21
Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
6:30am
6-K
15it50f j190
30 Aug 21
Innate Pharma to Participate in Upcoming Investor Conferences
6:30am
6-K
548v3 jp1
11 Aug 21
Current report (foreign)
6:30am
6-K
mk13ie0zylty6nqd
12 Jul 21
Current report (foreign)
6:30am
6-K
tclsz
6 Jul 21
Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
6:30am
6-K
9x1281kp
22 Jun 21
Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis Fungoides
7:00am
6-K
unz5wz
16 Jun 21
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
6:30am
6-K
pje tz6hl6
14 Jun 21
Current report (foreign)
6:30am
6-K
bbh7c ux2rptbuw4vf7
10 Jun 21
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
6:30am
6-K
25osvpm uhx3ct
9 Jun 21
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
6:30am
6-K
wf7hoqva3u2 61
28 May 21
Outcome of Innate Pharma’s Annual General Meeting
4:02pm
6-K
a38amey6
25 May 21
Current report (foreign)
6:30am
6-K
c9mf2mqi0dap siw4
12 May 21
Innate Pharma Virtual 2021 Annual General Meeting
6:30am
6-K
cj9kz9odswr4hrv22pq
11 May 21
Innate Pharma First Quarter 2021 Report
6:30am
6-K
jq9s1oob
4 May 21
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
6:05am